What Are the Signs H. pylori Is Dying?

There is no single dramatic sign that tells you H. pylori is dying mid-treatment. Instead, most people experience a gradual easing of the symptoms that brought them to the doctor in the first place: upper abdominal pain, bloating, nausea, and that gnawing burning sensation between meals. These improvements typically start during the antibiotic course itself and continue for weeks afterward as the stomach lining repairs. But the picture is messier than a clean before-and-after, because the antibiotics themselves can cause temporary discomfort that muddies the signal, and certain changes after successful eradication can feel counterintuitive.

What You Actually Feel During Treatment

The standard H. pylori treatment lasts about 10 to 14 days and involves two or more antibiotics combined with an acid-suppressing medication. During that window, many people notice their stomach pain and burning start to fade, sometimes within the first few days. This is partly because the acid-suppressing drug (usually a proton pump inhibitor) rapidly reduces stomach acid production, and partly because the bacterial population is declining. If your main symptom was a dull ache between meals or a burning feeling in the upper abdomen, you may notice it becoming less frequent or less intense before you even finish the prescription.

Nausea is one of the earliest symptoms to ease for many patients. The constant queasiness that H. pylori causes tends to lighten once acid levels drop and the bacteria thin out. That said, some people experience new nausea from the antibiotics themselves, which can make it hard to distinguish what is improving and what is a medication side effect. The general pattern to watch for is that the character of your discomfort shifts: the old, familiar H. pylori symptoms soften, even if new, drug-related ones pop up temporarily.

Treatment Side Effects That Can Feel Like Things Are Getting Worse

This is where people get confused. You start antibiotics expecting to feel better, and instead you develop diarrhea, a metallic taste in your mouth, or mild stomach cramps that are different from your usual symptoms. These are not signs of treatment failure. They are common side effects of the antibiotics used in triple or quadruple therapy regimens, particularly metronidazole and clarithromycin.

H. pylori eradication therapy disrupts gut bacteria well beyond just the target organism. Eradication treatment can shift the balance of intestinal microbes, increasing certain bacterial groups (like Proteobacteria) while decreasing others (like Actinobacteria, which help maintain gut stability). That decrease in beneficial Actinobacteria can persist for more than six months after treatment ends.

¹ This temporary imbalance is what drives the diarrhea, bloating, and sometimes even mild yeast overgrowth that patients report during and right after treatment. One study found that microbiome diversity bounced back to baseline about 42 days after eradication therapy, which suggests that for most people these disruptions are self-limiting within about six weeks.²

Adding probiotics to your treatment may help. Research consistently shows that supplementing with probiotics during H. pylori therapy is linked to higher eradication rates and fewer side effects like diarrhea.³ An umbrella review of multiple meta-analyses found that probiotic supplementation was associated with about a 10% improvement in eradication success and roughly halved the risk of total side effects compared with standard therapy alone.⁴ So if you are in the thick of treatment and feeling rough, that is usually the antibiotics doing their job on your wider gut ecosystem, not a sign that the H. pylori is winning.

How the Stomach Lining Heals After the Bacteria Are Gone

One of the clearest signs that H. pylori is dying, or has died, is what happens to your stomach lining over the following weeks and months. H. pylori causes chronic inflammation in the stomach (gastritis), and that inflammation does not vanish the moment antibiotics kill the last bacterium. It resolves in stages.

A study of patients treated with a standard one-week triple therapy found that acute inflammatory changes in the stomach lining had subsided in nearly all cases by four to five weeks after successful eradication, though about one in six patients still had some residual chronic inflammation at that point.⁵ In practical terms, this means your symptoms tend to improve steadily over the first month or two, but full healing can take longer. Long-term follow-up data shows that gastric lesions continue to regress for years after eradication, and that the healing rate actually accelerates the longer you stay infection-free. At 12 years out, people who stayed H. pylori-negative showed roughly 15% more regression of stomach lesions than those who remained positive.⁶

What this means for you is that symptom improvement is real but graded. Expect the sharpest relief in the first few weeks, followed by a slower, subtler improvement over the next several months. If you had H. pylori-related ulcers, ulcer healing takes its own timeline and your doctor may keep you on acid-suppressing medication beyond the antibiotic course to help that process along.

Blood Markers That Track the Shift

You will not get blood work just to see if H. pylori is dying, but if you are the type who follows your lab results, there are measurable changes that correspond to successful eradication. The pepsinogen system is the best-studied example. Pepsinogen I and pepsinogen II are enzymes produced by the stomach lining, and their levels in the blood reflect the state of the gastric mucosa. H. pylori infection drives pepsinogen II up disproportionately; successful eradication brings it back down.

In patients whose treatment worked, pepsinogen I dropped to about 70% of its pre-treatment value, while pepsinogen II fell even more steeply, to about 45% of its original level.⁷ The ratio between pepsinogen I and II increases substantially after successful eradication and barely budges in treatment failures, making it a surprisingly accurate biomarker. One study found that percentage changes in the pepsinogen I/II ratio could distinguish successful eradication from failure with about 93% accuracy.⁸ Long-term follow-up confirms these trends continue: pepsinogen levels and gastric histology both improve in parallel over months and years, suggesting that atrophic gastritis and even superficial gastritis are genuinely reversible once the infection is gone.⁹

These markers are useful mainly in research settings and in populations with high gastric cancer risk who undergo screening. Your doctor probably will not order a pepsinogen panel after a routine H. pylori treatment. But the data is reassuring: when the bacteria die, measurable chemical signs of stomach inflammation follow them down.

How Eradication Is Actually Confirmed

Symptom improvement alone is not reliable enough to confirm that H. pylori is dead. Some people feel dramatically better and still harbor the bacteria; others have lingering symptoms from a stomach that is still healing even though the infection is gone. The standard recommendation is to test at least four weeks after finishing treatment, and to be off proton pump inhibitors for at least two weeks before testing to avoid a false negative.

The urea breath test is the gold standard for confirming eradication. It works because live H. pylori produce an enzyme called urease that breaks down urea into carbon dioxide. You swallow a labeled urea tablet, and if H. pylori are still present, the labeled carbon dioxide shows up in your breath. In clinical studies, the urea breath test reaches about 95 to 99% sensitivity and close to 100% specificity for detecting active infection after treatment.¹⁰

Stool antigen tests are a reasonable alternative, though their performance in the post-treatment setting varies by the specific test used. Monoclonal stool antigen tests tend to outperform older polyclonal versions. In one head-to-head comparison, a monoclonal stool test achieved about 88% sensitivity for detecting remaining infection after treatment, compared with the breath test’s 99%.¹⁰ Some rapid point-of-care stool tests that you can get results from quickly in a clinic have shown poor reliability in confirming eradication and are generally not recommended for that purpose.¹¹ If you want to know whether the bacteria are truly gone, ask your doctor specifically about a urea breath test or a lab-based monoclonal stool antigen test, not a rapid dipstick result.

One concern patients sometimes raise is whether acid-suppressing drugs could mask ongoing infection and produce a falsely negative result. A real-world study that retested patients who had been confirmed negative while still on suppressive medications found that nearly all of them (about 98.5%) tested negative again when retested off those drugs, suggesting that false negatives from acid suppression may be less common in practice than often feared.¹² Still, following the recommended washout period before testing remains good practice.

Appetite and Weight Changes After Eradication

A change that surprises many people after successful H. pylori treatment is a noticeable shift in appetite or body weight. H. pylori colonizes the stomach lining and interacts with ghrelin and leptin, two hormones that regulate hunger and satiety. The exact direction of these changes has been debated in the research literature, and the evidence is genuinely mixed.

One study found that after eradication, post-meal ghrelin levels rose dramatically (nearly six-fold) and leptin levels also increased, which was associated with a modest but statistically significant weight gain of about 5% over 18 months in people who had been H. pylori-positive.¹³ A different study found that ghrelin actually decreased after eradication in both ulcer and gastritis patients, while leptin increased only in ulcer patients.¹⁴ And a more recent study found ghrelin levels dropped significantly after eradication but no change in weight was observed, concluding that there is no hormonal push toward weight gain after treatment.¹⁵

The bottom line on weight is that it varies. Some people gain a few pounds because their stomach feels better and they eat more comfortably. Others notice no change at all. If you find yourself hungrier than usual after treatment, that is not necessarily a sign something went wrong; it may simply reflect a stomach that is no longer inflamed and is sending stronger appetite signals. It is one of the more benign signs that the infection has cleared.

New Reflux After Treatment

Here is a change that catches people off guard. In some patients, getting rid of H. pylori can trigger new acid reflux symptoms, or reflux esophagitis visible on endoscopy. This has been documented primarily in Japanese populations, where roughly 10% of patients who undergo eradication therapy develop reflux esophagitis afterward.¹⁶ A separate study in the same population confirmed this figure and noted that reflux-related symptoms tended to improve over the 12 months following successful eradication, even in patients who had developed reflux esophagitis.¹⁷

The likely mechanism is that H. pylori infection in the body of the stomach can suppress acid production. Kill the bacteria and acid output rebounds, which can cause reflux in people who are anatomically predisposed to it (for example, those with a weak lower esophageal sphincter or a hiatal hernia). If you develop new heartburn after H. pylori treatment, mention it to your doctor, but know that it usually mellows out with time and is not a reason to regret treatment. The long-term benefits of eradication, including substantially reduced gastric cancer risk, outweigh the temporary inconvenience of reflux in the vast majority of cases.¹⁸

When Treatment Does Not Work

Not everyone’s H. pylori dies on the first round. Treatment failure is more common than many patients expect, particularly as antibiotic resistance to clarithromycin and metronidazole has climbed worldwide. If your symptoms have not improved four to six weeks after finishing treatment, or if a follow-up breath or stool test still comes back positive, you have not failed — the regimen has. The bacteria may have shifted into a more treatment-resistant form. Under antibiotic stress, H. pylori can transform into dormant coccoid shapes that are harder to kill, and these forms can survive exposure to antibiotics that would normally be effective against the rod-shaped active bacteria.¹⁹

The standard approach to treatment failure is to switch antibiotic classes. If your initial treatment was a clarithromycin-based regimen, your doctor will likely move to a metronidazole-based quadruple therapy or a fluoroquinolone-based combination next.²⁰ Most people do clear the infection on the second or third attempt. The key sign of failure is straightforward: persistent symptoms combined with a positive follow-up test. If the test is negative but you still feel off, the lingering symptoms are more likely the stomach still healing from the damage H. pylori already did, not ongoing infection.

Recurrence After Successful Eradication

Even after confirmed eradication, there is a small chance the infection returns. Globally, the annual recurrence rate sits at about 4.3%, which breaks down into two different scenarios: reinfection (catching a new strain from the environment, estimated at about 3.1% per year) and recrudescence (the original strain was suppressed rather than fully eliminated, at about 2.2% per year).²¹ Recurrence rates vary enormously by geography and living conditions. In high-income countries with good sanitation, reinfection is uncommon. In regions where H. pylori is highly prevalent and transmission routes (shared food, crowded living situations, untreated water) remain active, reinfection is a real concern.

The distinction between reinfection and recrudescence matters clinically. If your symptoms return within the first year after a negative confirmation test, recrudescence is more likely, and that may mean the original treatment did not fully eliminate the bacteria despite a negative test result.²² If symptoms return years later, a genuinely new infection is more plausible. Either way, returning symptoms paired with a positive test means retreatment is warranted.

The Long-Term Payoff of Eradication

The gradual fading of symptoms and the slow normalization of blood markers are signs worth paying attention to, but the biggest benefit of killing H. pylori plays out over years. A long-term follow-up study found that eradication cut gastric cancer risk by about 63% in people without pre-existing precancerous changes, and by roughly 43% overall regardless of what the stomach lining looked like at the time of treatment. A meta-analysis of randomized trials arrived at similar figures: a 46% reduction in gastric cancer incidence and a 39% reduction in gastric cancer mortality.¹⁸ These are large effects and they underscore why eradication is worth the temporary discomfort of treatment, even when the immediate symptom changes feel modest or hard to read. A small fraction of gastric cancers, roughly 3 to 5%, occur independently of H. pylori due to other causes, so eradication is not a complete shield. But it is a substantial one, and the risk reduction compounds the longer you stay free of the infection, as the stomach lining continues to heal and regress toward a healthier state over years of follow-up.⁶